Clinical Trial Update: Evaluating the Protective Effect of Pentoxifylline on Contrast Induced Nephropathy [NA]

View source ↗

Summary

An ongoing clinical trial from Shiraz University of Medical Sciences is evaluating whether pentoxifylline can protect against contrast-induced nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Nephropathy | NA | Status: UNKNOWN